Article Text

Download PDFPDF
Interstitial lung disease and leflunomide use
  1. V Aiyappan
  1. Senior House Office, Huddersfield Royal Infirmary, Huddersfield, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

There have been numerous reports of interstitial lung disease associated with the use of the new disease modifying anti-rheumatic drug leflunomide. This epidemiological study examined the risk of developing interstitial …

View Full Text